Safety, tolerability and pharmacokinetics of emodepside, a potential novel treatment for onchocerciasis (river blindness), in healthy male subjects-Reference-Cited by-同舟云学术

Safety, tolerability and pharmacokinetics of emodepside, a potential novel treatment for onchocerciasis (river blindness), in healthy male subjects

Published:2021-03-31 Issue:10 Volume:87 Page:3949-3960
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit Jnl Clinical Pharma

Author:

Gillon Jean‐Yves¹^ORCID,Dennison Jeremy²^ORCID,Berg Frans²³^ORCID,Delhomme Sophie¹,Dequatre Cheeseman Karen¹,Peña Rossi Claudia¹,Strub Wourgaft Nathalie¹^ORCID,Specht Sabine¹^ORCID,Pedrique Belén¹,Monnot Frédéric¹,Skrabs Susanne⁴,Rodriguez Maria‐Luisa⁴,Stass Heino⁴

Affiliation:

1. Drugs for Neglected Diseases initiative (DNDi) Geneva Switzerland

2. Hammersmith Medicines Research Ltd London UK

3. Invicro, Burlington Danes Building Imperial College London, Hammersmith Hospital London UK

4. Bayer AG Wuppertal Germany

Funder

Bill and Melinda Gates Foundation

Bundesministerium für Bildung und Forschung

United States Agency for International Development

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14816

Reference20 articles.

1. World Health Organisation.Onchocerciasis (river blindness) ‐ DiseaseInformationhttps://www.who.int/blindness/partnerships/onchocerciasis_disease_information/en/consultedon 14 April2020

2. Research for new drugs for elimination of onchocerciasis in Africa

3. Onchocerciasis Elimination: Progress and Challenges;Lakwo T;Res Rep Trop Med,2020

4. Phenotypic Evidence of Emerging Ivermectin Resistance in Onchocerca volvulus

5. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The long and winding road towards new treatments against lymphatic filariasis and onchocerciasis;Trends in Parasitology;2024-09

2. Efficacy and safety of emodepside compared with albendazole in adolescents and adults with hookworm infection in Pemba Island, Tanzania: a double-blind, superiority, phase 2b, randomised controlled trial;The Lancet;2024-08

3. Monovalent cation binding to model systems and the macrocyclic depsipeptide, emodepside;Journal of Computational Chemistry;2024-06-26

4. Onchocerciasis Drug Discovery: In Vitro Evaluation of FDA-Approved Drugs against Onchocerca gutturosa in Gambia;Pharmaceutics;2024-01-31

5. Efficacy and Safety of Emodepside Compared to Albendazole in Adolescents and Adults Infected with Hookworm in Pemba Island, Tanzania: A Double-Blind, Superiority, Phase 2b, Randomised Controlled Trial;2024